The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
Global Renin-Inhibitors main player is Noden Pharma, etc. Noden Pharma is dominating the market. USA is the largest market, with a share nearly 45%.
The global Renin-Inhibitors market was valued at US$ 85 million in 2020 and is expected to reach US$ 135.3 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
This report focuses on Renin-Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Renin-Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Renin-Inhibitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
150mg/Tablet
300mg/Tablet
Segment by Application
Age below 45
Age 45-55
Age 55-65
Age above 65
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
Noden Pharma
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
Global Renin-Inhibitors main player is Noden Pharma, etc. Noden Pharma is dominating the market. USA is the largest market, with a share nearly 45%.
The global Renin-Inhibitors market was valued at US$ 85 million in 2020 and is expected to reach US$ 135.3 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
This report focuses on Renin-Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Renin-Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Renin-Inhibitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
150mg/Tablet
300mg/Tablet
Segment by Application
Age below 45
Age 45-55
Age 55-65
Age above 65
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
Noden Pharma
Index1 Renin-Inhibitors Market Overview
1.1 Product Overview and Scope of Renin-Inhibitors
1.2 Renin-Inhibitors Segment by Type
1.2.1 Global Renin-Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 150mg/Tablet
1.2.3 300mg/Tablet
1.3 Renin-Inhibitors Segment by Application
1.3.1 Global Renin-Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Age below 45
1.3.3 Age 45-55
1.3.4 Age 55-65
1.3.5 Age above 65
1.4 Global Renin-Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Renin-Inhibitors Revenue 2016-2027
1.4.2 Global Renin-Inhibitors Sales 2016-2027
1.4.3 Renin-Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027
2 Renin-Inhibitors Market Competition by Manufacturers
2.1 Global Renin-Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global Renin-Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Renin-Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Renin-Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 Renin-Inhibitors Market Competitive Situation and Trends
2.5.1 Renin-Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Renin-Inhibitors Players Market Share by Revenue
2.5.3 Global Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Renin-Inhibitors Retrospective Market Scenario by Region
3.1 Global Renin-Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Renin-Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Renin-Inhibitors Market Facts & Figures by Country
3.3.1 North America Renin-Inhibitors Sales by Country
3.3.2 North America Renin-Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Renin-Inhibitors Market Facts & Figures by Country
3.4.1 Europe Renin-Inhibitors Sales by Country
3.4.2 Europe Renin-Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Renin-Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific Renin-Inhibitors Sales by Region
3.5.2 Asia Pacific Renin-Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Renin-Inhibitors Market Facts & Figures by Country
3.6.1 Latin America Renin-Inhibitors Sales by Country
3.6.2 Latin America Renin-Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Renin-Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa Renin-Inhibitors Sales by Country
3.7.2 Middle East and Africa Renin-Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Renin-Inhibitors Historic Market Analysis by Type
4.1 Global Renin-Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global Renin-Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global Renin-Inhibitors Price by Type (2016-2021)
5 Global Renin-Inhibitors Historic Market Analysis by Application
5.1 Global Renin-Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global Renin-Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global Renin-Inhibitors Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Renin-Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Renin-Inhibitors Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Noden Pharma
6.2.1 Noden Pharma Corporation Information
6.2.2 Noden Pharma Description and Business Overview
6.2.3 Noden Pharma Renin-Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Noden Pharma Renin-Inhibitors Product Portfolio
6.2.5 Noden Pharma Recent Developments/Updates
7 Renin-Inhibitors Manufacturing Cost Analysis
7.1 Renin-Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Renin-Inhibitors
7.4 Renin-Inhibitors Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Renin-Inhibitors Distributors List
8.3 Renin-Inhibitors Customers
9 Renin-Inhibitors Market Dynamics
9.1 Renin-Inhibitors Industry Trends
9.2 Renin-Inhibitors Growth Drivers
9.3 Renin-Inhibitors Market Challenges
9.4 Renin-Inhibitors Market Restraints
10 Global Market Forecast
10.1 Renin-Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Renin-Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Renin-Inhibitors by Type (2022-2027)
10.2 Renin-Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Renin-Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Renin-Inhibitors by Application (2022-2027)
10.3 Renin-Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Renin-Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Renin-Inhibitors by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Renin-Inhibitors Sales (K Tablet) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Renin-Inhibitors Sales (K Tablet) Comparison by Application (2021-2027)
Table 3. Global Renin-Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Renin-Inhibitors Covered in This Study
Table 5. Global Renin-Inhibitors Sales (K Tablet) of Key Manufacturers (2016-2021)
Table 6. Global Renin-Inhibitors Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Renin-Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Renin-Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Renin-Inhibitors Average Price (USD/K Tablet) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Renin-Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers Renin-Inhibitors Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Renin-Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renin-Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Renin-Inhibitors Sales by Region (2016-2021) & (K Tablet)
Table 16. Global Renin-Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global Renin-Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Renin-Inhibitors Sales by Country (2016-2021) & (K Tablet)
Table 19. North America Renin-Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America Renin-Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Renin-Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe Renin-Inhibitors Sales by Country (2016-2021) & (K Tablet)
Table 23. Europe Renin-Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe Renin-Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Renin-Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Renin-Inhibitors Sales by Region (2016-2021) & (K Tablet)
Table 27. Asia Pacific Renin-Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Renin-Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Renin-Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America Renin-Inhibitors Sales by Country (2016-2021) & (K Tablet)
Table 31. Latin America Renin-Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America Renin-Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Renin-Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Renin-Inhibitors Sales by Country (2016-2021) & (K Tablet)
Table 35. Middle East and Africa Renin-Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Renin-Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Renin-Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global Renin-Inhibitors Sales (K Tablet) by Type (2016-2021)
Table 39. Global Renin-Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global Renin-Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global Renin-Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global Renin-Inhibitors Price (USD/K Tablet) by Type (2016-2021)
Table 43. Global Renin-Inhibitors Sales (K Tablet) by Application (2016-2021)
Table 44. Global Renin-Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global Renin-Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global Renin-Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global Renin-Inhibitors Price (USD/K Tablet) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Renin-Inhibitors Sales (K Tablet), Revenue (Million US$), Price (USD/K Tablet) and Gross Margin (2016-2021)
Table 51. Novartis Renin-Inhibitors Product
Table 52. Novartis Recent Developments/Updates
Table 53. Noden Pharma Corporation Information
Table 54. Noden Pharma Description and Business Overview
Table 55. Noden Pharma Renin-Inhibitors Sales (K Tablet), Revenue (Million US$), Price (USD/K Tablet) and Gross Margin (2016-2021)
Table 56. Noden Pharma Renin-Inhibitors Product
Table 57. Noden Pharma Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Renin-Inhibitors Distributors List
Table 61. Renin-Inhibitors Customers List
Table 62. Renin-Inhibitors Market Trends
Table 63. Renin-Inhibitors Growth Drivers
Table 64. Renin-Inhibitors Market Challenges
Table 65. Renin-Inhibitors Market Restraints
Table 66. Global Renin-Inhibitors Sales Forecast by Type (2022-2027) & (K Tablet)
Table 67. Global Renin-Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Renin-Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Renin-Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Renin-Inhibitors Sales Forecast by Application (2022-2027) & (K Tablet)
Table 71. Global Renin-Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Renin-Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Renin-Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Renin-Inhibitors Sales Forecast by Region (2022-2027) & (K Tablet)
Table 75. Global Renin-Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Renin-Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Renin-Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Renin-Inhibitors
Figure 2. Global Renin-Inhibitors Market Share by Type in 2020 & 2027
Figure 3. 150mg/Tablet Product Picture
Figure 4. 300mg/Tablet Product Picture
Figure 5. Global Renin-Inhibitors Market Share by Application in 2020 & 2027
Figure 6. Age below 45
Figure 7. Age 45-55
Figure 8. Age 55-65
Figure 9. Age above 65
Figure 10. Global Renin-Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Renin-Inhibitors Market Size 2016-2027 (US$ Million)
Figure 12. Global Renin-Inhibitors Sales 2016-2027 (K Tablet)
Figure 13. Global Renin-Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Renin-Inhibitors Sales Share by Manufacturers in 2020
Figure 15. Global Renin-Inhibitors Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Renin-Inhibitors Players: Market Share by Revenue in 2020
Figure 17. Renin-Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Renin-Inhibitors Sales Market Share by Region (2016-2021)
Figure 19. Global Renin-Inhibitors Sales Market Share by Region in 2020
Figure 20. Global Renin-Inhibitors Revenue Market Share by Region (2016-2021)
Figure 21. Global Renin-Inhibitors Revenue Market Share by Region in 2020
Figure 22. U.S. Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Renin-Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Renin-Inhibitors by Type (2016-2021)
Figure 45. Sales Market Share of Renin-Inhibitors by Application (2016-2021)
Figure 46. Sales Market Share of Renin-Inhibitors by Application in 2020
Figure 47. Revenue Share of Renin-Inhibitors by Application (2016-2021)
Figure 48. Revenue Share of Renin-Inhibitors by Application in 2020
Figure 49. Manufacturing Cost Structure of Renin-Inhibitors
Figure 50. Manufacturing Process Analysis of Renin-Inhibitors
Figure 51. Renin-Inhibitors Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
